English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
FOXM1 and PD-L1 in CDK4/6-MEK resistance in nerve tumours
FOXM1 and PD-L1 in CDK4/6-MEK resistance in nerve tumours
Seeing double: Designing drugs that target “twin” cancer proteins
Seeing double: Designing drugs that target “twin” cancer proteins
Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer
Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer
Spiritual themes, distrust may factor into Black patients’ reluctance to participate in cancer clinical trials
Spiritual themes, distrust may factor into Black patients’ reluctance to participate in cancer clinical trials
CAR-T safe and effective on an outpatient basis in community hospitals
CAR-T safe and effective on an outpatient basis in community hospitals
Researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
Researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer...
Circular peptides in violets may aid in the fight against glioblastoma
Circular peptides in violets may aid in the fight against glioblastoma
Trial supports radiotherapy and cisplatin should remain the standard of care for p16+ oropharyngeal cancer
Trial supports radiotherapy and cisplatin should remain the standard of care for p16+ oropharyngeal cancer
Trial implies the addition of atezolizumab concurrently to standard of care does not improve survival in limited-stage small cell lung cancer
Trial implies the addition of atezolizumab concurrently to standard of care does not improve survival in limited...
Radon, even at levels below EPA guideline for mitigation, is linked to childhood leukemia
Radon, even at levels below EPA guideline for mitigation, is linked to childhood leukemia
<1...4546474849...784>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top